Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen E Beenken

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Microorganisms|April 26, 2025
<i>Staphylococcus aureus</i> Biofilm-Associated Infections: Have We Found a Clinically Relevant Target?Karen E Beenken, Mark S Smeltzer
Infection and Immunity|June 24, 2003
Mutation of sarA in Staphylococcus aureus limits biofilm formationKaren E Beenken, Jon S Blevins, Mark S Smeltzer
Infection and Immunity|November 29, 2024
The ability of <i>sarA</i> to limit protease production plays a key role in the pathogenesis of <i>Staphylococcus aureus</i> osteomyelitis irrespective of the functional status of <i>agr</i>Karen E Beenken, Mara J Campbell, Mark S Smeltzer
Infection and Immunity|February 23, 2012
Impact of extracellular nuclease production on the biofilm phenotype of Staphylococcus aureus under in vitro and in vivo conditionsKaren E Beenken, Horace Spencer, Linda M Griffin, et al.
Virulence|February 7, 2023
The major role of <i>sarA</i> in limiting <i>Staphylococcus aureus</i> extracellular protease production <i>in vitro</i> is correlated with decreased virulence in diverse clinical isolates in osteomyelitisMara J Campbell, Karen E Beenken, Aura M Ramirez, et al.
Mbio|February 28, 2024
Increased production of aureolysin and staphopain A is a primary determinant of the reduced virulence of <i>Staphylococcus aureus sarA</i> mutants in osteomyelitisMara J Campbell, Karen E Beenken, Aura M Ramirez, et al.
Infection and Immunity|January 18, 2002
Strain-dependent differences in the regulatory roles of sarA and agr in Staphylococcus aureusJon S Blevins, Karen E Beenken, Mohamed O Elasri, et al.
Clinical Orthopaedics and Related Research|January 5, 2017
Phosphatidylcholine Coatings Deliver Local Antimicrobials and Reduce Infection in a Murine Model: A Preliminary StudyMichael A Harris, Karen E Beenken, Mark S Smeltzer, et al.
Clinical Microbiology Reviews|April 16, 2026
Mechanistic insights into the pathogenesis and therapeutic recalcitrance of <i>Staphylococcus aureus</i> osteomyelitisKaren E Beenken, Mara J Campbell, Humberto Reyes-Pardo, et al.
Plos One|October 11, 2008
Factors contributing to the biofilm-deficient phenotype of Staphylococcus aureus sarA mutantsLaura H Tsang, James E Cassat, Lindsey N Shaw, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Microorganisms|April 26, 2025
<i>Staphylococcus aureus</i> Biofilm-Associated Infections: Have We Found a Clinically Relevant Target?Karen E Beenken, Mark S Smeltzer
Infection and Immunity|June 24, 2003
Mutation of sarA in Staphylococcus aureus limits biofilm formationKaren E Beenken, Jon S Blevins, Mark S Smeltzer
Infection and Immunity|November 29, 2024
The ability of <i>sarA</i> to limit protease production plays a key role in the pathogenesis of <i>Staphylococcus aureus</i> osteomyelitis irrespective of the functional status of <i>agr</i>Karen E Beenken, Mara J Campbell, Mark S Smeltzer
Infection and Immunity|February 23, 2012
Impact of extracellular nuclease production on the biofilm phenotype of Staphylococcus aureus under in vitro and in vivo conditionsKaren E Beenken, Horace Spencer, Linda M Griffin, et al.
Virulence|February 7, 2023
The major role of <i>sarA</i> in limiting <i>Staphylococcus aureus</i> extracellular protease production <i>in vitro</i> is correlated with decreased virulence in diverse clinical isolates in osteomyelitisMara J Campbell, Karen E Beenken, Aura M Ramirez, et al.
Mbio|February 28, 2024
Increased production of aureolysin and staphopain A is a primary determinant of the reduced virulence of <i>Staphylococcus aureus sarA</i> mutants in osteomyelitisMara J Campbell, Karen E Beenken, Aura M Ramirez, et al.
Infection and Immunity|January 18, 2002
Strain-dependent differences in the regulatory roles of sarA and agr in Staphylococcus aureusJon S Blevins, Karen E Beenken, Mohamed O Elasri, et al.
Clinical Orthopaedics and Related Research|January 5, 2017
Phosphatidylcholine Coatings Deliver Local Antimicrobials and Reduce Infection in a Murine Model: A Preliminary StudyMichael A Harris, Karen E Beenken, Mark S Smeltzer, et al.
Clinical Microbiology Reviews|April 16, 2026
Mechanistic insights into the pathogenesis and therapeutic recalcitrance of <i>Staphylococcus aureus</i> osteomyelitisKaren E Beenken, Mara J Campbell, Humberto Reyes-Pardo, et al.
Plos One|October 11, 2008
Factors contributing to the biofilm-deficient phenotype of Staphylococcus aureus sarA mutantsLaura H Tsang, James E Cassat, Lindsey N Shaw, et al.
Pageof 6